[Skip to Content]

Standards

Safety Alert – Zeiss Lucia 611P intraocular lens

Apr 10
2019

The College has been made aware of two ophthalmic units with a run of a small number of cases of fibrin membrane deposition in association with the Zeiss Lucia 611P intraocular lens. In these cases, the patients presented from a few days up to 6 weeks postoperatively, with a painless white eye, very mild or

  • 10 April 2019

NICE publishes serious eye disorders quality standard

Feb 12
2019

The Royal College of Ophthalmologists supports the quality standard but believes the implementation will be challenging for the overwhelmed hospital eye service.  The National Institute for Health and Care Excellence (NICE) has published its first quality standard looking at serious eye disorders, covering the diagnosis and management of cataracts, glaucoma and age-related macular degeneration (AMD)

  • 12 February 2019

Public registration open to register to observe the Quality Standards Advisory committee meeting for serious eye disorders

Jun 13
2018

The National Institute for Health and Care Excellence (NICE) has opened the public registration facility to observe the Quality Standards Advisory committee meeting for serious eye disorders on the NICE website. Registration can be completed via https://www.nice.org.uk/event/qsac1-july-2018 and will close on Thursday 21 June 2018.  NICE are not able to accept late requests to observe this meeting. As

  • 13 June 2018

Ophthalmic Safety Alert – Diabetic control and safe cataract surgery

May 01
2018

The College has received queries from members to clarify whether there is a specific cut off for glycaemic control, either measured via HbA1C or a blood glucose level on the day, beyond which it is unsafe to proceed with cataract surgery. There is anecdotal evidence of cataract surgery cases being cancelled for surgery if their

  • 1 May 2018

Ophthalmic Safety Alert – intracameral cefuroxime

May 01
2018

There are a range of cefuroxime preparations currently in use for the prevention of endophthalmitis in intraocular surgery. There are two licensed versions, Aprokam (Thea Pharmaceuticals) and  Ximaract (from Bausch & Lomb), both available as a  50mg powder and diluent solution for injection.  Also used are unlicensed prefilled syringes, of which some are compliant with

  • 1 May 2018